DOI QR코드

DOI QR Code

호스피스케어와 전통적 의료서비스 이용간의 사망전 의료비용 비교

Comparison of Medical Care Cost between Hospice Care and Conventional Care in the Last Year of life

  • 최귀선 (국립암센터 국가암관리사업지원평가연구단) ;
  • 유창훈 (국립암센터 국가암관리사업지원평가연구단) ;
  • 이경희 (서울대학교 보건대학원) ;
  • 김창엽 (서울대학교 보건대학원) ;
  • 허대석 (서울대학교병원 내과) ;
  • 윤영호 (국립암센터 국가암관리사업지원평가연구단)
  • Choi Kui Son (National Cancer Center, Research Institute for National Cancer Control and Evaluation) ;
  • You Chang Hoon (National Cancer Center, Research Institute for National Cancer Control and Evaluation) ;
  • Lee Kyoung Hee (Seoul National University, School of Public Health) ;
  • Kim Chang Yup (Seoul National University, School of Public Health) ;
  • Heo Dae Seog (Seoul National University Hospital, Department of Internal Medicine) ;
  • Yun Young Ho (National Cancer Center, Research Institute for National Cancer Control and Evaluation)
  • 발행 : 2005.06.01

초록

The aim of this study was to compare medical cost of hospice care and that of conventional care during the last year of life, and identify factors that influenced the cost. From January to August 2003 592 terminal cancer patients receiving care from 5 hospice care units and 2 hospice care teams in general hospitals were enrolled to case group. Two hundreds and seventy two terminal cancer patients receiving conventional care from 7 general hospitals were enrolled to hospital-based control group, and 1,636 terminal cancer patients from 122 general hospitals located in same regions with the 7 hospitals were enrolled to community-based control. We used characteristics and medical cost from data of National Health Insurance Cooperation. Total medical cost per beneficiary in cases was about 10 millions won, 14.5 millions in hospital-based controls and 11.1 millions in community-based controls. The hospice care saved $45\%$ over the last year of life compared with hospital-based controls (p<0.0001). Saving of inpatient cost account for approximately $80\%$ of saving per beneficiary. Hospice care saved $29\%$ of medical cost per hospitalization day compared with hospital­based controls and $17\%$ compared with community-based controls (p<0.0001). Multiple regression analyses showed that hospice care significantly saved the medical cost. This study suggest that hospice care save medical cost compared with hospital-based control and community-based control. Most of saving of inpatient cost account for approximately $80\%$ of saving of medical cost.

키워드

참고문헌

  1. 국립암센터. 한국 호스피스.완화의료 제도화.2002
  2. 박노례, 윤영호, 신순애, 정은경. 암환자의 사망전 6개월의 의료비용. 한국호스피스 완화의료학회지 1999;2:109-113
  3. 보건복지부. 한국중앙암등록본부, 한국중앙암동록사업 연례보고서; 2003
  4. 윤영호, 허대석. 말기 암환자의 3차의료기간 입원의 문제점. 대한가정의학회지 1996; 17(5): 294 - 304
  5. 윤영호, 허대석, 전효이, 유태우, 김유영, 허봉렬. 말기암 환자들의 의료이용행태. 대한가정의학회지 1998;19 (6):445-51
  6. 윤영호, 이영선, 이정석, 이창걸, 김시영, 정은영 등. 암환자와 가족 입장에서 본 호스피스 완화의료 제도화. 가정의학회지 2002;23:1042-51
  7. 윤영호. 말기암 환자의 관리의 시스템 구축. 말기암 환자의 삶의 질, 이대로 좋은가? 호스피스, 완화의료 심포지엄 자료집, 서울: 국립암센터, 2001;37: 45
  8. 허대석, 윤영호, 정주영, 김홍수, 김성혜, 신상도, 김중의. 암 환자 응급진료의 현황 및 문제점. 한국호스피스. 완화의료학회지 1998;1(1):13-21
  9. 허봉렬, 박노례, 김승택, 윤영호, 배종면, 이영성. 진행암환자 관리의 문제점 분석 및 호스피스관리 체계 개발에 관한 연구. 암정복추진연구개발사업 지원 제 2차년도 최종보고서. 서울; 보건복지부, 2000
  10. 호스피스. 완화의료사업지원평가단. 보건복지부. 말기암환자 호스피스 사업 최종결과 보고서. 2004
  11. Bayer R, Callahan D, Fletcher J. The care of the tenninally ill: mortality and economics. N Engl J Med 1983;309:1490-1494 https://doi.org/10.1056/NEJM198312153092405
  12. Brooks C. Smyth-Staruch K Hospice home care cost savings to third-party insurers. Med Care 1984;22:691-703 https://doi.org/10.1097/00005650-198408000-00002
  13. Emanuel EJ. Cost savings at the end of life: What do the data show? JAMA 1996;275:1907-1914 https://doi.org/10.1001/jama.275.24.1907
  14. Garber AM, MaCurdy TM, McClellan ML. Medical Care at the end of life: diseases, treatment patterns, and cots, NBER Working paper;1998:6748
  15. Gray D, MacAdam D, Boldy D. A comparative cost analysis of tenninal cancer in home hospice patients and controls. J Chron Dis 1987;40(8):801-810 https://doi.org/10.1016/0021-9681(87)90132-9
  16. Kane R, Wales J, Bernstein L, Leibowitz A, Kaplan S. A randomized controlled trial of hospice care. Lancet 1984;1: 890-894
  17. Kidder D. The effect of hospice coverage on Medicare expenditure, Health Sev Res 1992; 27(2): 195-217
  18. Lo JC. The impact of hospices on health care expendituresihe case of Taiwan, Soc Sci Med 2002;54:981-991 https://doi.org/10.1016/S0277-9536(01)00071-5
  19. Lubitz JD, Riley GF. Trends in medicare payment in the last year of life. N Engl J Med 1983;328:1002-1096 https://doi.org/10.1056/NEJM199304083281404
  20. Mor V, Kidder D. Cost savings in hospice: final results of the National Hospice Study. Health Serv Res 1985;20:407-421
  21. Spector W, Mor V. Utilization and charges for tenninal cancer patients in Rhode Island. Inquiry 1984;21:328-337

피인용 문헌

  1. Economic Evaluation of Companion Diagnostic Testing for EGFR Mutations and First-Line Targeted Therapy in Advanced Non-Small Cell Lung Cancer Patients in South Korea vol.11, pp.8, 2016, https://doi.org/10.1371/journal.pone.0160155
  2. Educational Differences in Health Care Utilization in the Last Year of Life among South Korean Cancer Patients vol.40, pp.1, 2007, https://doi.org/10.3961/jpmph.2007.40.1.36